Hana Yoshida
Ask VT AI
View News Summary
- Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
- Former LSU coach Ed Orgeron expresses strong interest in returning to the program following Brian Kelly's dismissal.
- US adult obesity rate declines as weight-loss drug use surges in 2025, but diabetes prevalence reaches new high.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
- Former LSU coach Ed Orgeron expresses strong interest in returning to the program following Brian Kelly's dismissal.
- US adult obesity rate declines as weight-loss drug use surges in 2025, but diabetes prevalence reaches new high.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Hana Yoshida
News from Hana Yoshida
